Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.20)
# 3,414
Out of 4,826 analysts
319
Total ratings
32.28%
Success rate
-18.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Buy | $45 → $50 | $33.67 | +48.50% | 2 | May 1, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.40 | +218.18% | 12 | Apr 30, 2025 | |
| EDIT Editas Medicine | Initiates: Buy | $3 | $1.58 | +90.48% | 1 | Apr 28, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $72 | $60.85 | +18.32% | 35 | Apr 25, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $33.41 | +124.48% | 37 | Apr 16, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Neutral | $75 | $64.28 | +16.68% | 11 | Apr 16, 2025 | |
| LYEL Lyell Immunopharma | Reiterates: Neutral | $1 | $0.44 | +127.27% | 12 | Apr 16, 2025 | |
| VERV Verve Therapeutics | Maintains: Buy | $15 → $25 | $5.12 | +388.28% | 6 | Apr 14, 2025 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $40 | $12.66 | +215.96% | 17 | Apr 9, 2025 | |
| RLYB Rallybio | Downgrades: Neutral | n/a | $0.32 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.47 | +415.12% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $2.14 | +86.92% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.57 | +347.28% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.47 | +104.78% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.56 | +254.61% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.08 | +733.33% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.50 | +185.71% | 19 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $50 | $15.59 | +220.72% | 14 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.45 | +132.56% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $18.60 | +518.28% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.96 | - | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $14.11 | +679.87% | 14 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $8.54 | +251.49% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $27.80 | +58.27% | 13 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $37.82 | +71.87% | 2 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $10.07 | +346.87% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.22 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $2.23 | +27,354,160.09% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.78 | - | 4 | Jun 2, 2023 | |
Ionis Pharmaceuticals
May 1, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $33.67
Upside: +48.50%
Alumis
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $4.40
Upside: +218.18%
Editas Medicine
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $1.58
Upside: +90.48%
Halozyme Therapeutics
Apr 25, 2025
Reiterates: Buy
Price Target: $72
Current: $60.85
Upside: +18.32%
Legend Biotech
Apr 16, 2025
Reiterates: Buy
Price Target: $75
Current: $33.41
Upside: +124.48%
Sarepta Therapeutics
Apr 16, 2025
Reiterates: Neutral
Price Target: $75
Current: $64.28
Upside: +16.68%
Lyell Immunopharma
Apr 16, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.44
Upside: +127.27%
Verve Therapeutics
Apr 14, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $5.12
Upside: +388.28%
Cartesian Therapeutics
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.66
Upside: +215.96%
Rallybio
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.32
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $23
Current: $4.47
Upside: +415.12%
Apr 3, 2025
Maintains: Neutral
Price Target: $6 → $4
Current: $2.14
Upside: +86.92%
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.57
Upside: +347.28%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.47
Upside: +104.78%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.56
Upside: +254.61%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $10.50
Upside: +185.71%
Mar 25, 2025
Maintains: Buy
Price Target: $55 → $50
Current: $15.59
Upside: +220.72%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $6.45
Upside: +132.56%
Mar 20, 2025
Reiterates: Buy
Price Target: $115
Current: $18.60
Upside: +518.28%
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.96
Upside: -
Mar 5, 2025
Reiterates: Buy
Price Target: $110
Current: $14.11
Upside: +679.87%
Mar 5, 2025
Initiates: Buy
Price Target: $30
Current: $8.54
Upside: +251.49%
Feb 25, 2025
Reiterates: Buy
Price Target: $44
Current: $27.80
Upside: +58.27%
Feb 13, 2025
Reiterates: Buy
Price Target: $65
Current: $37.82
Upside: +71.87%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $10.07
Upside: +346.87%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.22
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $2.23
Upside: +27,354,160.09%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.78
Upside: -